Managing Challenging Bioanalysis for PK/PD assessments for Phase I Biologic Read more about Managing Challenging Bioanalysis for PK/PD assessments for Phase I Biologic
The Many Facets of Early Phase Evaluation of Psychedelics in Psychiatry Read more about The Many Facets of Early Phase Evaluation of Psychedelics in Psychiatry
The Brain on Drugs: The Strategic Use of Cognitive Measures and Biomarkers in Early-Phase CNS Drug Studies Read more about The Brain on Drugs: The Strategic Use of Cognitive Measures and Biomarkers in Early-Phase CNS Drug Studies
The Heart of the Matter - Early vs. Late QT Prolongation Testing Read more about The Heart of the Matter - Early vs. Late QT Prolongation Testing
To Control or be Controlled – Navigating the abuse potential evaluation of CNS-active drugs for EU and US submissions Read more about To Control or be Controlled – Navigating the abuse potential evaluation of CNS-active drugs for EU and US submissions
Comparing CTA Submission (EMA/Health Canada) to IND Applications (FDA) for Phase I Trials Read more about Comparing CTA Submission (EMA/Health Canada) to IND Applications (FDA) for Phase I Trials
Assessing Cognition and Driving Ability in Clinical Pharmacology Studies Read more about Assessing Cognition and Driving Ability in Clinical Pharmacology Studies
Quantitation of Passive Immunotherapeutic Agents for COVID-19 by LC-MS Read more about Quantitation of Passive Immunotherapeutic Agents for COVID-19 by LC-MS
Overcoming the Challenges of Manufacturing and Clinical Trials Read more about Overcoming the Challenges of Manufacturing and Clinical Trials
Navigating Early Phase CNS-Active Drug Development with Dr. Beatrice Setnik, CSO Read more about Navigating Early Phase CNS-Active Drug Development with Dr. Beatrice Setnik, CSO